Cost-effectiveness of upper endoscopy for gastric cancer screening and surveillance in Western populations

While routine endoscopic screening may not be cost-effective in Western populations, surveillance for GIM every three to five years is economically sustainable. Higher-risk individuals with dysplasia or incomplete GIM may benefit from more frequent surveillance.